BL-RX01-TFSTAB-1402

Part of paid clinical trials in Sioux Falls, South Dakota.

Sponsor
Vance Thompson Vision
Study ID
NCT07790211
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Determine the ability of the iTrace™, BOSA™, OPD-Scan III, and IDRA to detect tear film stability utilizing Miebo® — DRUG
    Determine the ability of the iTrace™, BOSA™, OPD-Scan III, and IDRA to detect tear film stability utilizing Miebo® by examining potential differences in various tear film assessments before dosing Miebo® and at multiple timepoints post-Miebo® dosing

Study Details

A study to investigate the ability of the iTrace™, BOSA™, OPD-Scan III, and IDRA to detect tear film stability utilizing Miebo®

Key Dates

First listed
Aug 27, 2026
Start date
Aug 31, 2026
Status verified
Aug 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Determine ability of iTrace™ BOSA™ OPD-Scan III & IDRA to detect tear film stability utilizing Miebo
    Miebo administered once in each eye on Visit One and Visit Two

Primary Outcome Measure

Number of subjects with an increase from baseline of the Tear Film Index as assessed by the iTrace [ Time Frame: Compared from baseline to post-administration times at 5 minutes, 30 minutes, and 1 hour at both Visit One and Visit Two ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vance Thompson VisionSioux FallsSouth Dakota57108
Kayla Karpuk, OD
[email protected]
605-361-3937

Find similar trials in Sioux Falls, SD

By research site
Vance Thompson Vision· Sioux Falls, SD

Related Studies